MicroVention raises $19 million for MicroPlex launch:
This article was originally published in Clinica
Executive Summary
MicroVention, which develops minimally invasive products for the treatment of cerebral vascular diseases, has closed a $19m round of venture capital funding. The Aliso Viejo, California-based company says the new funds will be used to support the second-quarter launch of its MicroPlex coil system and to accelerate sales and marketing of its HydroCoil embolic system for the treatment of cerebral aneurysms. Some 150,000 people are treated for cerebral aneurysms worldwide annually, with 20% undergoing an endovascular coil embolisation procedure, MicroVention says.